Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus erythematosus (SLE) have been revealed, and have not disappointed.

Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...

For the year 2024, the global gross domestic product (GDP) was about USD 114 trillion. Total assets under management (AUM) of the asset management industry worldwide were around USD 128 trillion (112 ...